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could underline the severity of the
clinical phenotype, but systematic
analyses need to be undertaken before
any firm conclusions can be drawn. 
Why mutations in LMNA result in
such a wide range of apparently distinct
phenotypes is unknown. However, the
identification of overlapping lamin-
associated disorders indicates that they
represent a functional continuum of
related disorders rather than separate
diseases. 
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eventually replace such nomenclatures
as “muscular dystrophy with
lipodystrophy”. Mandibuloacral
dysplasia is usually listed in the
differential diagnoses of Hutchinson-
Gilford progeria (most commonly
caused by G608G mutation, as
pointed out by Gisele Bonne and
Nicolas Levy); we now know how
these two disorders are related.
Bonne and Levy, and C Vigouroux
and colleagues would like us to
compare phenotypes of our patients
with those of two patients published
since submission of our report. One of
them, reported by Caux and
colleagues, is a 27-year-old man 
with childhood-onset generalised
lipodystrophy who had the same
R133L heterozygous LMNA mutation
as that reported in two of our patients.
All three patients had scleroderma-
like skin, early onset diabetes mellitus,
and greying or thinning of hair; all
signs suggestive of Werner’s
syndrome. Our patients might be too
young to conclude that cataracts are
or are not associated with this
mutation. One of the female patients
reported by us had short stature and
hypogonadism, whereas the patient
reported by Caux and colleagues had
normal height and normal sexual
maturation. The extent to which our
patients with the R133L mutation
have generalised or partial
lipodystrophy, hepatic steatosis, or
abnormal lipid profiles remains to be
ascertained. 
The other published case with the
L140P mutation (not R140P as stated
by Bonne and Levy) describes a 
13-year-old boy with EDMD without
progeroid features. Our 34-year-old
patient with a heterozygous L140R
mutation presented with various
progeroid features, including bilateral
ocular cataracts (figure). We agree
with Bonne and Levy that specific
aminoacid substitutions at positions
140 and 527 of lamin A/C can result
in different phenotypes.
The R527P mutation reported in
EDMD and cardiomyopathy was
heterozygous, whereas the R527H
mutation seen in patients with
mandibuloacral dysplasia was
homozygous.1 Whether individuals
with the heterozygous R527C
mutations have any phenotype
remains unclear, since the 28-year-old
lady reported by Cao and Hegele with
apparently typical Hutchinson-Gilford
progeria was a compound heterozy-
gote with R527C and R471C
mutations. In fact, the patient had
clavicular resorption, multiple
fractures, and acro-osteolysis, features
more suggestive of mandibuloacral
dysplasia than Hutchinson-Gilford
progeria. 
Much more research is certainly
needed to sort out the pathogenetic
mechanisms that underlie this
fascinating set of disorders. 
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Authors’ reply
Sir—The University of Washington
International Registry of Werner
Syndrome was set up in 1987 to
collect information on patients with
Werner’s syndrome from all over the
world based on a set of clinical
criteria, providing definite, probable,
or possible diagnoses. The database
was established before the WRN and
LMNA genes were identified; only
those cases classed as definite or
probable were used for the positional
cloning experiments that lead to the
discovery of the WRN locus.
Clinicians worldwide subsequently
submitted cases with overlapping
progeroid features, a minor subset of
whom had the LMNA mutations
described in our report. In
accordance with the trend to
categorise disorders on the basis of
the responsible genes instead of
clinical symptoms or pathological
findings, the term laminopathy would
be an appropriate designation for the
growing set of disorders caused by
LMNA mutations, and might
Patient with LMNA R140L mutation
Note thinning and greying of hair, pinched nose,
and lack of subcutaneous fat on face without
any mandibular hypoplasia. 
Globalisation of
prevention education: a
golden lecture  
Sir—John S Yudkin and colleagues
(Sept 6, p 822),1 argue that teaching
of international health to medical
students in the UK will help to
provide a greater understanding of the
global trends of disease. Here, we
describe how we gave a single lecture
on disease prevention to more than
75% of the countries of the world.
Improvements in hygiene and in
our knowledge of how to prevent
disease have led to a worldwide gain
in life expectancy of 30 years over the
20th century. The way in which
preventive medicine is taught has,
however, hardly changed. The
importance of disease prevention 
was recognised as early as the 
5th Century AD by Hippocrates of
Cos. Hippocrates taught that a proper
diet is a necessity of health, and that
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climate has a profound effect on both
mind and body. In Greece, Sept 19 is
celebrated as Hippocrates day, and in
May, 2003, those involved in the
Supercourse Prevention project
(http://www.pitt.edu/~super1), funded
by the US National Institutes of
Health (NIH), suggested that the day
be used to spread worldwide the
message of disease prevention. As
such, on Sept 19, we posted the
“Golden Lecture of Prevention” on
the internet. The supercourse is an
internet library of lectures on
prevention, shared for free by 10 000
members from 151 countries in the
Global Health Network. The golden
lecture was designed to teach
preventive approaches to health. 
Leading researchers from more
than 30 countries, including Russia,
Nepal, Cuba, Armenia, and several
Islamic states, participated in the
creation of the lecture, which is
especially important for the
developing world, where doctors and
researchers are struggling to find cost-
effective ways to improve their
population’s health. 
We distributed the golden lecture to
doctors, professors, public-health
professionals, and instructors by Sept
1, 2003, to be read and taught until
and on Hippocrates day. To improve
access to the lecture, we made two
formats available. Over the next
several months, the lecture was
translated into 12 languages,
including Chinese, Russian, Spanish,
Arabic, Indonesian, and Croatian. All
of these materials were uploaded to
the Supercourse website at http://
www.pitt.edu/~super1/lecture/lec1051
1/index.htm. Overall, the lecture was
used in 136 of the 189 UN-recognised
countries. 
Our aim was to reach educators in
as many countries as possible. We
believe the time has come to globalise
training in health and share our
knowledge. 
We thank the members of the Global Health
Network for their contribution. Please contact
FL to obtain a copy of the Golden lecture of
prevention and a free supercourse with 1038
lectures.
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predefined search criteria. In July,
2003, this service detected the
appearance of an unusual Salmonella
species from submitted stools in one
of our hospital emergency
departments. Since four of the seven
patients presented in a short period of
time (<24 h), observant practitioners
caring for these patients also reported
the event. The computer system
automatically detected this event and
reported it as an alert needing
investigation.
This small cluster of cases was 
found to represent a portion of 
patients made ill from contaminated
food at a local restaurant. Salmonella
javiana is an unusual, but recognised,
cause of foodborne disease,4 and its
detection in outpatients by an
automated system monitoring a
clinical microbiology database is a
clear example of what we should come
to expect from emerging technology.
Such systems can uncover small
changes in complex patterns and
provide infection-control professionals
with opportunities to intervene 
before limited clusters of preventable
infections become expansive out-
breaks. Dutch investigators have
described their introduction of a
nationally comprehensive, albeit some-
what less technologically sophisticated,
hypothesis-based screening of micro-
biology laboratory data for outbreak
detection, and plan to cover 35% of
their population by 2006.5 These kinds
of developments provide a vision for
21st century innovations that can
expand our capacity to detect and treat
clusters of infectious diseases, thus
limiting their spread and improving
patients’ safety.
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Retinal detachment
Sir—The public and the medical
profession—especially ophthalmologists
—should be aware that reports by
patients of “floaters”, “seeing spots”, or
“triangles” in their field of vision are
meaningless until their cause can been
ascertained. Precious time was lost for
the patient described by Jennifer Ng and
colleagues (Aug 23, p 639)1 and many
unnecessary tests were done; cycloplegic
fundoscopy is all that was needed.
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Detection of a community
infection outbreak with
virtual surveillance
Sir—The Joint Commission on
Accreditation of Healthcare Organi-
zations for US hospitals (JCAHO) is
continuing to strengthen organisation-
wide infection control practice in
inpatient and outpatient settings.1
J P Burke has suggested that a
potential approach for expanding
surveillance is the use of new
computer technologies capable of
detecting small patterns of change in
vast amounts of computer data
available in clinical microbiology
laboratory information systems.2 One
of the innovations mentioned was the
use of data mining as a means for
automated, enhanced, organisation-
wide detection of infection outbreaks.3
Evanston Northwestern Healthcare
is a three-hospital academic health-
care system with nearly 800 inpatient
beds. In 2002, the 1700 physicians on
the medical staff cared for more than
43 000 inpatients. These physicians
also saw 91 000 patients in the
emergency departments and exper-
ienced over 390 000 outpatient visits.
About 53% of the specimens
processed by the clinical microbiology
laboratory at our institution result
from these outpatient visits, providing
potential surveillance opportunities in
the community as well as the hospital.
In October, 2002, we began to use a
new surveillance service created by
MedMined (Birmingham, AL, USA)
which uses artificial intelligence,
statistics, and database technology
(“data mining”) to capture large
amounts of existing microbiology
data. These data are analysed for
meaningful patterns of organisms and
patients without manual entry or
